Showing results (1-10 of 1,316) with videos related to
Sort By:
Pageof 132
Bio-Protocol|September 20, 2021
Soft Agar Colony Formation Assay as a Hallmark of CarcinogenesisFeng Du, Xiaodi Zhao, Daiming FanCritical Reviews in Oncogenesis|April 2, 2018
Epithelial-to-Mesenchymal Transition: Liaison between Cancer Metastasis and Drug ResistanceFeng Du, Hao Liu, Yuanyuan Lu, et al.Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|December 30, 2022
[N6-methyladenosine (m6A) binding protein hnRNPA2B1 is highly expressed in a variety of tumors and regulates tumor immune microenvironment]Jiayao Wang, Xiaodi Zhao, Yuanyuan Lu, et al.Current Cancer Drug Targets|October 31, 2013
MicroRNAs as critical regulators involved in regulating epithelial- mesenchymal transitionXiaodi Zhao, Yuanyuan Lu, Yongzhan Nie, et al.Cancer Letters|January 13, 2025
Modulating the gut microbiota: A novel perspective in colorectal cancer treatmentXue Bai, Boyang Liu, Daiming Fan, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 18, 2017
MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting MAML3 and WHSC1 in gastric cancerJinjing Li, Tingyu Li, Yuanyuan Lu, et al.Cancer Communications (London, England)|July 7, 2018
DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathwaysFeng Du, Lina Sun, Yi Chu, et al.Cancer Biology & Medicine|January 30, 2026
Gut microecology empowers cancer immunotherapy: commensal microbiota-mediated mechanisms and translational prospects of PD-1/PD-L1 therapySifan Li, Chang Che, Yelu Zhou, et al.International Journal of Biological Sciences|October 21, 2021
Immunotherapy in colorectal cancer: current achievements and future perspectiveAhui Fan, Boda Wang, Xin Wang, et al.Pageof 132